Homeopathic treatment of ringworm

Validation of translated Bengali version of Skindex-29 questionnaire in Tinea infection and open observational trial to evaluate effectiveness of individualized homeopathic treatment

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/08/015318

Enrollment

Registered

2018-08-13

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B35- Dermatophytosis Health Condition 2: B359- Dermatophytosis, unspecified

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal or 50 millesimal potencies: Individualized homoeopathic medicines will be prescribed in individualized dosage as per homeopathic prin

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from any kind of tinea infection 2. Age 18-65 years 3. Both sexes 4. Literate patients; ability to read English and/or Bengali 5. Providing written informed consent 6. Patient using topical agents for tinea lesions will be included after a washout period of two weeks

Exclusion criteria

Exclusion criteria: 1. Cases with complication like lichenification and eczematisation 2. Similar looking skin conditions; e.g. seborrhic dermatitis, pityriasis rosea and some types of psoriasis 3. Patients who are too sick for consultation, unable to read patient information sheet, unwilling to take part or not giving consent to join the study 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 5. Pregnant women and lactating mothers 6. Substance abuse and/or dependence 7. Self-reported immune-compromised state, and 8. Already undergoing homeopathic treatment for chronic disease within last 6 months

Design outcomes

Primary

Measure	Time frame
Size of lesion and 0-10 numeric rating scale measuring intensity of pruritusTimepoint: Baseline, after 3 months and after 6 months	—

Secondary

Measure	Time frame
Dermatological Life Quality Index (DLQI) questionnaireTimepoint: Baseline, after 3 months and after 6 months;Skindex-29 questionnaireTimepoint: Baseline, after 3 months and after 6 months	—

Countries

India

Contacts

Public ContactSimantini Ghosh

Mahesh Bhattacharyya Homoeopathic Medical College & Hospital, Govt. of West Bengal

ghosh.simantini@gmail.com9836174575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026